Literature DB >> 169308

Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.

P A Brunell, A A Gershon, S A Uduman, S Steinberg.   

Abstract

Antibodies to membrane antigens of cells infected by varicella-zoster virus were detected by immunofluorescence. Rises in varicella-zoster IgA, IgG, and tigM were detected after both varicella and zoster. Prompt antibody responses were observed in patients with generalized zoster as well as in those with localized zoster. A delayed response was found, moreover, in one patient who did not develop disseminated disease. Antibody to varicella-zoster virus was detected in the sera of all three patients tested prior to and in all but one of 63 patients tested soon after onset of zoster. The level of varicella-zoster IgA and IgG rose in two of three immune patients after household exposure to infection with varicella-zoster virus. Varicella-zoster IgG was detected in the cord blood of infants whose mothers were immune to varicella.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169308     DOI: 10.1093/infdis/132.1.49

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.

Authors:  A M van Loon; J T van der Logt; F W Heessen; M C Heeren; J Zoll
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

2.  Specific immunoglobulin responses after varicella and herpes zoster.

Authors:  J E Cradock-Watson; M K Ridehalgh; M S Bourne
Journal:  J Hyg (Lond)       Date:  1979-04

3.  Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation?

Authors:  N E Cremer; V L Devlin; J L Riggs; S J Hagens
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques.

Authors:  I Sarov; E Levy; M Aymard; Y Chardonnet; S Bosshard; J P Revillard; M Friedman; E Nord; M Greiff; H Haikin
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

5.  Social epidemiology of chickenpox in two British national cohorts.

Authors:  J I Pollock; J Golding
Journal:  J Epidemiol Community Health       Date:  1993-08       Impact factor: 3.710

6.  Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.

Authors:  A Schattner; N Hanuka; B Sarov; I Sarov; Z Handzel; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

7.  Determination of specific IGA antibodies to varicella zoster virus by immunoperoxidase assay.

Authors:  H Haikin; I Sarov
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

8.  Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.

Authors:  A A Gershon; S Steinberg; M Smith
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

9.  Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid.

Authors:  A Gershon; S Steinberg; S Greenberg; L Taber
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

10.  Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus.

Authors:  J Shanley; M Myers; B Edmond; R Steele
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.